AngioDynamics Inc.

26.35+0.2500+0.96%Vol 140.65K1Y Perf 198.75%
Jul 27th, 2021 15:23 DELAYED
BID26.31 ASK26.38
Open26.02 Previous Close26.10
Pre-Market- After-Market-
 - -%  - -
Target Price
30.00 
Analyst Rating
Hold 3.00
Potential %
13.77 
Finscreener Ranking
     42.17
Insiders Trans % 3/6/12 mo.
-/-100/- 
Value Ranking
★★+     50.14
Insiders Value % 3/6/12 mo.
-/-100/25 
Growth Ranking
★★     44.48
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/61 
Income Ranking
 —    -
Market Cap1.00B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
82.43 
Earnings Date
13th Jul 2021

Today's Price Range

25.5126.39

52W Range

8.0530.25

5 Year PE Ratio Range

-83.1058.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
1.12%
1 Month
-6.45%
3 Months
5.16%
6 Months
37.22%
1 Year
198.75%
3 Years
21.85%
5 Years
57.32%
10 Years
91.35%

TickerPriceChg.Chg.%
ANGO26.350.25000.96
AAPL146.72-2.2700-1.52
GOOG2 727.65-65.2400-2.34
MSFT286.09-2.9600-1.02
XOM57.66-0.8200-1.40
WFC45.120.11000.24
JNJ172.280.41000.24
FB366.37-6.0900-1.64
GE13.110.19001.47
JPM151.45-0.2000-0.13
Financial StrengthValueIndustryS&P 500US Markets
1.50
2.40
0.04
0.05
-40.90
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
53.90
-62.40
-53.00
-56.40
-10.76
RevenueValueIndustryS&P 500US Markets
291.01M
7.63
-5.15
-5.72
Earnings HistoryEstimateReportedSurprise %
Q04 20210.000.00-
Q03 2021-0.030.02166.67
Q02 2021-0.020.01150.00
Q01 2021-0.060.02133.33
Q04 2020-0.05-0.06-20.00
Q03 2020-0.030.01133.33
Q02 20200.020.06200.00
Q01 20200.040.08100.00
Earnings Per EndEstimateRevision %Trend
8/2021 QR-0.04--
11/2021 QR0.01-66.67Negative
5/2022 FY0.01-91.67Negative
5/2023 FY0.17-26.09Negative
Next Report Date-
Estimated EPS Next Report-
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume140.65K
Shares Outstanding38.14M
Trades Count1.87K
Dollar Volume4.06M
Avg. Volume286.12K
Avg. Weekly Volume126.47K
Avg. Monthly Volume266.00K
Avg. Quarterly Volume220.27K

AngioDynamics Inc. (NASDAQ: ANGO) stock closed at 26.1 per share at the end of the most recent trading day (a -0.23% change compared to the prior day closing price) with a volume of 125.94K shares and market capitalization of 1.00B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 800 people. AngioDynamics Inc. CEO is James C. Clemmer.

The one-year performance of AngioDynamics Inc. stock is 198.75%, while year-to-date (YTD) performance is 70.25%. ANGO stock has a five-year performance of 57.32%. Its 52-week range is between 8.05 and 30.25, which gives ANGO stock a 52-week price range ratio of 82.43%

AngioDynamics Inc. currently has a PE ratio of -31.90, a price-to-book (PB) ratio of 2.27, a price-to-sale (PS) ratio of 3.42, a price to cashflow ratio of 41.60, a PEG ratio of 2.32, a ROA of -5.19%, a ROC of -30.32% and a ROE of -6.71%. The company’s profit margin is -10.76%, its EBITDA margin is -53.00%, and its revenue ttm is $291.01 Million , which makes it $7.63 revenue per share.

Of the last four earnings reports from AngioDynamics Inc., there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. AngioDynamics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for AngioDynamics Inc. is Hold (3), with a target price of $30, which is +13.77% compared to the current price. The earnings rating for AngioDynamics Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

AngioDynamics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

AngioDynamics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.54, ATR14 : 1.17, CCI20 : -61.18, Chaikin Money Flow : -0.09, MACD : 0.04, Money Flow Index : 40.24, ROC : -4.47, RSI : 48.73, STOCH (14,3) : 30.37, STOCH RSI : 0.81, UO : 49.96, Williams %R : -69.63), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of AngioDynamics Inc. in the last 12-months were: David D. Helsel (Sold 3 500 shares of value $83 755 ), Howard W. Donnelly (Option Excercise at a value of $83 829), James C. Clemmer (Buy at a value of $330 400), Stephen A. Trowbridge (Buy at a value of $9 502), Wesley E. Johnson (Sold 6 500 shares of value $120 445 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (100.00 %)
3 (100.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
3.00
Hold
3.00
Moderate Buy
2.00

AngioDynamics Inc.

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

CEO: James C. Clemmer

Telephone: +1 518 795-1400

Address: 14 Plaza Drive, Latham 12110, NY, US

Number of employees: 800

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

60%40%

Bearish Bullish

58%42%

News

Stocktwits